Health & Fitness

Cardiac Scientists at Wynnewood's Lankenau Release Report on 'J Wave Syndromes'

The report aims to educate health care professionals on how to diagnose J Wave Syndromes, arrhythmic conditions that lead to sudden death.

Wynnewood, PA -- Scientists at Lankenau Institute for Medical Research have issued a report on "J Wave Syndromes" that aims to educate health care professionals on how to diagnose arrhythmic conditions that lead to sudden death.

Two cardiovascular experts from Lankenau led an international task force to develop a first-of-its-kind consensus report and book on J Wave Syndromes, an increasingly researched cause of ventricular fibrillation responsible for sudden cardiac death, according to a press release.

The publications follow months of work from a task force of cardiac specialists from 17 biomedical facilities from around the world, led by Charles Antzelevitch, Ph.D., professor and executive director of cardiovascular research at LIMR and director of research at LHI, along with Gan-Xin Yan, M.D., Ph.D., professor at LIMR and clinical cardiologist at Lankenau Medical Center, Lankenau said.

Find out what's happening in Ardmore-Merion-Wynnewoodfor free with the latest updates from Patch.

A book, titled “J Wave Syndromes,” will accompany the manuscript J Wave Syndromes Expert Consensus Conference Report – the latter of which will be published simultaneously in the medical journals Heart Rhythm, Journal of Arrhythmiaand EP-Europace, the release states.

The Consensus Report and book were written to assist the health care community in understanding the underlying mechanisms that lead to these syndromes, how to diagnose them and how to treat them, the press release states.

Find out what's happening in Ardmore-Merion-Wynnewoodfor free with the latest updates from Patch.

“While the ultimate judgment regarding care of a particular patient must be made by the health care provider based on all of the facts and circumstances presented, our Expert Consensus Report is intended to assist health care professionals in their clinical decision making,” Dr. Antzelevitch said in the release. “It is designed to keep physicians fully informed as to new genetic information, diagnostic criteria, risk stratification strategies and approaches to therapy for these serious heart conditions.”

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.